Danish pharmaceutical company Lundbeck will release its third-quarter report on Wednesday.
Expected adjusted EBITDA, according to the company’s consensus based on estimates from twelve analysts, is DKK 1,953 million. In the corresponding period last year, the result was DKK 2,051 million.
The company will release the report before the market opens and hold a conference call at 13.00.
H. LundbeckReport date2026-11-11(DKK million)Q3-2026, forecastNumber of estimatesPrevious yearSales6 354126 279Adjusted EBITDA1 953122 051Source: The company
Share price performance at the latest reports as follows:
PeriodReport dateQ2-20262026-08-19Q1-20262026-05-12Q4-20252026-02-04Q3-20252025-11-12Q2-20252025-08-13Q1-20252025-05-14Q4-20242025-02-05Q3-20242024-11-13
